DAX24.498 +1,1%ESt505.387 +0,8%Top 10 Crypto15,88 +2,4%Dow45.010 +1,1%Nas21.020 +0,6%Bitcoin100.953 +0,2%Euro1,1765 ±-0,0%Öl69,18 +0,7%Gold3.371 -0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 SAP 716460 Tesla A1CX3T Deutsche Bank 514000 Mercedes-Benz Group (ex Daimler) 710000 RENK RENK73 BASF BASF11 Volkswagen (VW) vz. 766403 Lufthansa 823212 Siemens Energy ENER6Y Novo Nordisk A3EU6F BYD A0M4W9 Bayer BAY001 Clara Technologies A3E4MS
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Vor EZB-Zinsentscheid: DAX stark -- Asiens Börsen in Grün -- Tesla verfehlt Gewinnerwartungen - Umsatz leicht über Prognose -- Amazon, Alphabet, Vodafone, BYD, Deutsche Bank, IBM im Fokus
Top News
Zoll-Optimismus treibt an: DAX zeigt sich vor EZB-Zinsentscheid fest - Rekord in Sichtweite Zoll-Optimismus treibt an: DAX zeigt sich vor EZB-Zinsentscheid fest - Rekord in Sichtweite
BYD-Aktie im Aufwärtstrend: Analysten sehen Expansionsstrategie als Schlüssel zum Erfolg BYD-Aktie im Aufwärtstrend: Analysten sehen Expansionsstrategie als Schlüssel zum Erfolg
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Co-Diagnostics Aktie

Handeln
Aktien-Sparplan anlegen
0,2240 EUR -0,0140 EUR -5,88 %
FSE
0,2830 USD -0,0160 USD -5,35 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.8,26 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2DU6V

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS1897631057

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolCODX

Co-Diagnostics Aktien News

DatumMeistgelesen
PR NewswireCo-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25
PR NewswireCo-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa
PR NewswireCo-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28
PR NewswireCo-Diagnostics, Inc. to Participate in 6th ACTC Conference in Skiathos, Greece
PR NewswireCo-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21
PR NewswireCo-Diagnostics, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023
PR NewswireCo-Diagnostics, Inc. Appoints Chief Regulatory Affairs Officer
PR NewswireCo-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.
PR NewswireCo-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, Thailand
PR NewswireCo-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results
PR NewswireCo-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast
PR NewswireCo-Diagnostics, Inc. to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim, CA
PR NewswireCo-Diagnostics, Inc. Announces Recent Grant Awards
PR NewswireCo-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program
PR NewswireCo-Diagnostics, Inc. Reports First Quarter 2023 Financial Results
PR NewswireCo-Diagnostics, Inc. Announces First Quarter 2023 Earnings Release Date and Webcast
PR NewswireCo-Diagnostics, Inc. to Host Booth at 67th Annual CARPHA Conference April 27-29
PR NewswireCo-Diagnostics, Inc. to Host Booth at ECCMID 2023 April 15-18 in Copenhagen, Denmark
PR NewswireCo-Diagnostics, Inc. to CEO to Deliver Keynote Address at 2023 MarketsandMarkets Conference in London, England
PR NewswireCo-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22
PR NewswireCo-Diagnostics, Inc. Reports Full Year 2022 Financial Results
PR NewswireCO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS RELEASE DATE AND WEBCAST
PR NewswireCo-Diagnostics, Inc. to Present and Host Booth at TRI-CON in San Diego, CA, March 6-8
PR NewswireCo-Diagnostics, Inc. to Host Booth at 89th Annual AMCA Conference in Reno, NV on Feb 28-March 3
PR NewswireCo-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR Home™ Platform
PR NewswireCo-Diagnostics, Inc. to Host Booth at Medlab Middle East 2023 in Dubai on February 6-9
PR NewswireCo-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test Design
PR NewswireCo-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8
PR NewswireCo-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022
PR NewswireCo-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany
PR NewswireCo-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results
PR NewswireCo-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ
PR NewswireCo-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer
PR NewswireCO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST
PR NewswireCo-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa
PR NewswireCo-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand
PR NewswireCODX LAWSUIT ALERT: Levi & Korsinsky Notifies Co-Diagnostics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireCODX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Co-Diagnostics, Inc. Shareholders
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - CODX
PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Co-Dx Investors of a Lead Plaintiff Deadline of October 17, 2022

Co-Diagnostics News

Co-Diagnostics News: auf dieser Seite finden Sie alle Co-Diagnostics News und Nachrichten zur Co-Diagnostics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Co-Diagnostics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Co-Diagnostics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.